The vascular endothelial growth factor (VEGF) is a key signaling pathway in vascular endothelial cells, and studies have shown that inhibiting the VEGF by targeting angiogenesis is an effective approach to lung cancer treatment [8]. This evidence concerns the gene VEGFA and lung carcinoma.